All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 152 of 206 pages ‹ First < 150 151 152 153 154 > Last ›
HSL9779
Madsen S, Huse J, Roksvaag PO.
Pharmacy customers' attitude to generics
Tidsskrift for den Norske Laegeforening 2003;123:(6):792-793
HSL9789
Akram G, Roberts K.
Pharmacists' management of over-the-counter medication requests from methadone patients
Journal of Substance Use 2003;8:(4):215 - 222
HSL9793
Ekedahl A.
Unused Drugs Returned to Pharmacies - A Few Patients Return a Large Proportion of the Unused Drugs
Journal of Social and Administrative Pharmacy 2003;20:(6):257-258
HSL9795
Overo J.
OTC antifungal drugs [2] (multiple letters)
Ugeskrift for Laeger 2003;165:(9):933-934
HSL9879
Husain N.
Challenges for pharmacists in India
Pharmaceutical Journal 2003;271:(7280):885-886
HSL9880
Mason P.
Pharmacy in Australia
Pharmaceutical Journal 2003;271:(7280):883-884
HSL9881
Ludzker DH.
Let us not follow the United States [4]
Pharmaceutical Journal 2003;271:(2779):812
HSL9882
Two developments widen availability of oseltamivir for 'flu
Pharmaceutical Journal 2003;271:(7279):805
HSL9886
Work in progress
Veterinary Record 2003;153:(25):761-762
HSL9888
Ganestam F, Lundborg CS, Grabowska K, Cars O, Linde A.
Weekly antibiotic prescribing and influenza activity in Sweden: a study throughout five influenza seasons.
Scand J Infect Dis 2003;35:(11-12):836-42
HSL9892
Rhodes J.
Components of the Pharmaceutical Industry Are Converging
BioPharm International 2003;16:(12):106
HSL9893
Wechsler J.
Risk Management and Pricing Concerns Shaped FDA Policy in 2003
BioPharm International 2003;16:(12):16-17
HSL9894
Wilson KA, Jesson J .
Dispensing activity in a community pharmacy-based repeat dispensing pilot project
International Journal of Pharmacy Practice 2003;11:(4):225-232
HSL9897
Thalidomide
Australian Prescriber 2003;26:(6):150-151
HSL9898
Glokler C, Graefe T.
Advertising OTC drugs at reduced prices
Deutsche Apotheker Zeitung 2003;143:(48):73-77
HSL9899
Muller-bohn T.
The combination model and its implications: Business administration for the pharmacy 2004: Part 3
Deutsche Apotheker Zeitung 2003;143:(48):65-69
HSL9900
Herzog R.
Acting in crisis. Part 4: Future price fixing in the OTC segment - A question of survival!
Deutsche Apotheker Zeitung 2003;143:(48):56-64
HSL9903
Schmidt E, Wong R.
'New' FDA delivers in 2003
Nature Reviews Drug Discovery 2003;2:(12):941-942
HSL9904
Reprimand for pharmacist who endorsed erroneous scripts for £3,700 overpayment
Pharmaceutical Journal 2003;271:(7277):757
HSL9905
A new standard coding system for reporting patient safety incidents
Pharmaceutical Journal 2003;271:(7277):749
HSL9914
Voelker R.
Northern Rxposure: US, Canada Clash on Cross-Border Medication Sales
Journal of the American Medical Association 2003;290:(22):2921-2925
HSL9915
Muller-Bohn T
How much is the OTC trade worth? Part 4
Deutsche Apotheker Zeitung 2003;143:(49):65-69
HSL9916
May U.
Effects of the German public health system modernization act on the over-the counter medicines market
Pharmazeutische Industrie 2003;65:(11):1085-1092
HSL9917
Goldenberg MM.
Drug Safety Revisions: FDA Update
P and T 2003;28:(8):
HSL9918
Nash DB.
The AMCP's Drug Dossier Format
P and T 2003;28:(10):624
HSL9919
Thawani V, Pande S, Turankar A.
Nicotine replacement drug being sold on pavement shops
Indian Journal of Pharmacology 2003;35:(6):402, 403
http://www.doaj.org/openurl?genre=article&issn=0253-7613&volume=35&issue=6&spage=402
HSL9920
Adcock H.
Statin set to become next big POM-to-P switch: Is this good news for patients?
Pharmaceutical Journal 2003;271:(7276):705
HSL9921
Scopoderm reclassification
Pharmaceutical Journal 2003;271:(7276):704
HSL9922
Statins form part of the PAGB's draft OTC advertising guidance
Pharmaceutical Journal 2003;271:(7276):699
HSL9923
Simvastatin could become a pharmacy medicine within the next six months
Pharmaceutical Journal 2003;271:(7276):699
HSL9924
Telmisartan + hydrochlorothiazide
Prescrire International 2003;12:(68):219
HSL9925
Appearances can be deceptive
Prescrire International 2003;12:(68):202
HSL9926
Szelag A, Merwid-lad A, Trocha M, Skrzypiec M, Smereka A.
Pathomechanisms of drug hepatotoxicity
Gastroenterologia Polska 2003;10:(5):425-9
HSL9929
Perkins ML.
Talk to local GPs [9]
Pharmaceutical Journal 2003;271:(7274):645
HSL9931
Glass HE.
Series of regulatory rulings guide FDA decision making
Drug Benefit Trends 2003;15:8-11
HSL9936
Decaudin B, Vion D.
To carry out a drug prescription "outside of authorized marketing demand" in hospital pharmacy. Example is prescription of oxybate sodium
Biofutur 2003;(238):44-46
HSL9941
Massive illegal supplies of co-proxamol lead to striking-off and reprimand
Pharmaceutical Journal 2003;271:(7273):629-630
HSL9942
Postcode prescribing review
Pharmaceutical Journal 2003;271:(7273):604
HSL9946
McLeod RL, Tulshian DB, Hey JA.
Novel pharmacological targets and progression of new antitussive drugs
Expert Opinion on Therapeutic Patents 2003;13:(10):1501-1512
HSL9948
GSK's Paxil given notice
Nature Reviews Drug Discovery 2003;2:(5):342
HSL9955
Potter JE, Moore AM, Byrd TL.
Cross-border procurement of contraception: estimates from a postpartum survey in El Paso, Texas
CONTRACEPTION 2003;68:(4):281-7
http://linkinghub.elsevier.com/retrieve/pii/S001078240300177X
HSL9956
Bellingham C.
How self-care is being made a reality
Pharmaceutical Journal 2003;271:(7270):486
HSL9957
OTC omeprazole approved for heartburn
WHO Drug Information 2003;17:(3):170
HSL10234
Nimesulide temporarily suspended
WHO Drug Information 2003;17:(3):169
HSL10235
Lyndon B.
Should psychiatrists lie to access suitable treatment for their patients?
Australasian Psychiatry 2003;11:(3):347-349
http://www.blackwell-synergy.com/rd.asp?code=APY&vol=11&page=347&goto=abstract
HSL10236
Jose VM.
Recent trends in the utilization of 'NSAIDs' in a tertiary care hospital
Indian Journal of Pharmacology 2003;35:(5):318-319
http://www.doaj.org/openurl?genre=article&issn=0253-7613&volume=35&issue=5&spage=318
HSL10238
How to help pharmacists and the industry be allies in concordance
Pharmaceutical Journal 2003;271:(7269):467-468
HSL10239
Faking it
Pharmaceutical Journal 2003;271:(2769):436
HSL10240
Hutton N.
Does mass marketing have a future?
Pharmaceutical Journal 2003;271:(7268):424
HSL10242
Morgan SG, Mintzes B, Barer M.
The economics of direct-to-consumer advertising of prescription-only drugs: Prescribed to improve consumer welfare?
Journal of Health Services Research and Policy 2003;8:(4):237-244
HSL10243
Allen LaPointe NM, Pamer CA, Kramer JM.
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance
Pharmacotherapy 2003;23:(10):1316-1321
HSL10246
'Unsatisfactory' for over-the-counter St. John's wort preparations
Deutsche Apotheker Zeitung 2003;143:(40):51
HSL10250
Wechsler J.
Counterfeiting, compliance and controls
Pharmaceutical Technology Europe 2003;15:(9):
HSL10251
Cannabis-based medicines - GW Pharmaceuticals. High CBD, high THC, medicinal cannabis - GW Pharmaceuticals, THC:CBD
Drugs in R and D 2003;4:(5):306-309
HSL10253
Laplanche A.
Heparin prevention during hospitalisation in medical wards?
Prescrire International 2003;12:(67):198-199
HSL10254
Generic version of OTC loratadine comes to market
Formulary 2003;38:(9):518
HSL10255
Ariza Ariza R.
How to avoid the gastrointestinal pain in the treatment of arthrosis. Cost-benefit approximation of the different alternatives in the Spanish market
Seminarios de la Fundacion Espanola de Reumatologia 2003;4:(3):93-103
HSL10256
Promise of patent extension in return for studies in children improves safety
Pharmaceutical Journal 2003;271:(7265):288
HSL10257
Coloured-pack generic range to expand
Pharmaceutical Journal 2003;271:(7265):286
HSL10258
Chapman LWJ.
Opening a can of worms [1]
Pharmaceutical -Journal 2003;271:(7264):260
HSL10260
Abraham J.
Learning from drug disasters and reforming medicines regulation
Critical Public Health 2003;13:(3):269-279
HSL10262
Rapley M.
I want, therefore I am: A tribute to David Smail
Clinical Psychology 2003;(24):13-19
HSL10268
Tent M.
Why doctors sometimes prescribe drugs which are more expensive than necessary: Favors can get under your skin
Pharmaceutisch Weekblad 2003;138:(33-34):1163
HSL10271
Bjornsdottir I, Hansen EH, Grimsson A.
Choosing among antibiotic products: General practitioners' path while prescribing
Journal of Social and Administrative Pharmacy 2003;20:(4):118-124
HSL10272
Buying medicines on the world wide web: What is legal and what is not?
Pharmaceutical Journal 2003;271:(7262):202
HSL10273
CoMedis aims for 4,000 online users
Pharmaceutical Journal 2003;271:(7262):198
HSL10274
Lifting advertising ban could lead to more switches to pharmacy medicines
Pharmaceutical Journal 2003;271:(7262):198
HSL10275
World wide worry
Pharmaceutical Journal 2003;271:(7262):194
HSL10276
Abasolo E, Hermosilla-najera L, Guijarro J, Ramos-saiz EM, Abecia LC.
Minimised antimicrobial cost analysis at a Health Care Centre
Pharmaceutical Care Espana 2003;5:(3):132-8
HSL10277
Medicines in mind
Veterinary Record 2003;153:(8):221
HSL10278
Morphine oral - Elan Corporation: Avinza
Drugs in R and D 2003;3:(3):208-209
HSL10280
Shipman inquiry: Views on tightening of controlled drug regulations sought
Pharmaceutical Journal 2003;271:(2761):171-172
HSL10281
Balit CR, Isbister GK, Dawson A, Daly FF, Whyte IM, Hender EA, Raftos J, Kisely SR, Lawrence D, Preston NJ.
The effect of recalling paracetamol on hospital admissions for poisoning (multiple letters)
Medical Journal of Australia 2003;179:(4):221-3
HSL10282
Telithromycine and myasthenia gravis
WHO Drug Information 2003;17:(2):104-105
HSL10288
Kang JY, Majeed A, Lewis JD, Bilker WB, Brensinger C, Farrar JT, Strom BL.
Hospitalization and mortality rates from peptic ulcer in the 1990s [3] (multiple letters)
American Journal of Gastroenterology 2003;98:(8):1896-1897
http://ezproxy.library.uq.edu.au/login?url=http://dx.doi.org/10.1016/S0002-9270(03)00502-1 Blackwell-Synergy http://www.blackwell-synergy.com/rd.asp?code=AJG&vol=98&page=1896&goto=abstract
HSL10290
Support for changes in BVA structure
Veterinary Record 2003;154:(4):101-104
HSL10291
Wang L.
AstraZeneca pleads guilty to criminal conspiracy
Journal of the National Cancer Institute 2003;95:(14):1037
HSL10354
New stroke warning for OTC products
Pharmaceutical Journal 2003;271:(7257):39
HSL10357
Birkett DJ.
Generics - Equal or not?
Australian Prescriber 2003;26:(4):85-87
HSL10363
Performance of sales representatives in France: Still bad
Prescrire International 2003;12:(66):153
HSL10364
Paroxetine withdrawal syndrome
Prescrire International 2003;12:(66):141
HSL10365
Zofenopril
Prescrire International 2003;12:(66):140
HSL10367
Wechsler J.
Debate escalates over follow-on biologics
BioPharm International 2003;16:(7):12-14
HSL10368
Harman RJ.
Legislation for medicines and product liability - A review of UK and European controls
Pharmaceutical Journal 2003;270:(7255):904
HSL10372
Golubtsov B, Kermani F.
Coming of age in CEE
Good Clinical Practice Journal 2003;10:(7):15-18
HSL10374
Baele PL.
Miss-'n-mix and mimics Batch DM 998
Acta Anaesthesiologica Belgica 2003;54:(2):149-150
HSL10375
Reissman D.
Selling the benefits of mail
Drug Benefit Trends 2003;15:(6):
HSL10376
Wechsler J.
Changes in Congress and FDA shape healthcare policy
Formulary 2003;38:(2):113-115
HSL10379
Wechsler J.
Bush budget outlines healthcare priorities
Formulary 2003;38:(3):168-171
HSL10380
Clarke PMW.
Educate the public by making supplements P medicines [7]
Pharmaceutical Journal 2003;270:(7249):682
HSL10381
Altagracia MM, Kravzov JJ, Moreno SR, Rios CC, Vazquez ME.
Self-medication in rural and urban communities in the state of Guerrero, Mexico
Revista Mexicana de Ciencias Farmaceuticas 2003;34:(2):27-35
HSL10382
Gomez BJV, De-denis ME, Pereda-reyna O.
Antihypertensive medications used by specialist physicians and factors that influence the prescription
Revista Mexicana de Ciencias Farmaceuticas 2003;34:(2):21-26
HSL10411
Most pharmacists recommend most medicines they sell
Pharmaceutical Journal 2003;270:(7253):817
HSL10412
Evaluating e-pharmacy
Medicine Today 2003;4:(6):
HSL10413
Lowe R.
There should be one brand name for one drug
Pharmaceutical Journal 2003;270:(7252):792
HSL10416
Dewa CS, Hoch JS.
Fixed and flexible formularies as cost-control mechanisms
Expert Review of Pharmacoeconomics and Outcomes Research 2003;3:(3):303-315
HSL10417
Broom D.
Big yellow taxi, or, unhealthy terms of trade?
Aust N Z J Public Health 2003;27:(3):271-2
HSL10418
Any questins?
Veterinary Record 2003;152:(22):672-674
HSL10419
Pharmacists propose new POM category
Veterinary Record 2003;152:(22):670
HSL10420
An uphill struggle on medicines
Veterinary Record 2003;152:(22):669-670
Page 152 of 206 pages ‹ First < 150 151 152 153 154 > Last ›
